tech:

taffy

Exscientia, GlaxoSmithKline ink £33 million AI-driven drug discovery partnership

Exscientia, a company that uses artificial intelligence and machine learning for drug discovery,  has entered into a collaboration with GlaxoSmithKline (GSK).

The company will receive research payments from GSK to undertake new discovery programs with nominated targets with the goal of delivering pre-clinical candidates. In addition to research funding, Exscientia is also eligible to receive near-term lead and pre-clinical candidate milestones. The total amount payable by GSK to Exscientia on achieving these milestones is £33 million.

During this collaboration, Exscientia will work with GSK to discover molecules for disease-related targets.

[Image courtesy: GSK]

Just in

Tembo raises $14M

Cincinnati, Ohio-based Tembo, a Postgres managed service provider, has raised $14 million in a Series A funding round.

Raspberry Pi is now a public company — TC

Raspberry Pi priced its IPO on the London Stock Exchange on Tuesday morning at £2.80 per share, valuing it at £542 million, or $690 million at today’s exchange rate, writes Romain Dillet. 

AlphaSense raises $650M

AlphaSense, a market intelligence and search platform, has raised $650 million in funding, co-led by Viking Global Investors and BDT & MSD Partners.

Elon Musk’s xAI raises $6B to take on OpenAI — VentureBeat

Confirming reports from April, the series B investment comes from the participation of multiple known venture capital firms and investors, including Valor Equity Partners, Vy Capital, Andreessen Horowitz (A16z), Sequoia Capital, Fidelity Management & Research Company, Prince Alwaleed Bin Talal and Kingdom Holding, writes Shubham Sharma. 

Capgemini partners with DARPA to explore quantum computing for carbon capture

Capgemini Government Solutions has launched a new initiative with the Defense Advanced Research Projects Agency (DARPA) to investigate quantum computing's potential in carbon capture.